共 50 条
- [1] THE RELATIVE BENEFIT AND RISKS OF INTRAVENOUS STREPTOKINASE AND TISSUE PLASMINOGEN-ACTIVATOR IN ACUTE MYOCARDIAL-INFARCTION [J]. RISK/BENEFIT ANALYSIS FOR THE USE AND APPROVAL OF THROMBOLYTIC, ANTIARRHYTHMIC, AND HYPOLIPIDEMIC AGENTS, 1989, : 23 - 28
- [2] ALTEPLASE - A TISSUE PLASMINOGEN-ACTIVATOR FOR ACUTE MYOCARDIAL-INFARCTION [J]. DRUG INTELLIGENCE & CLINICAL PHARMACY, 1988, 22 (01): : 6 - 14
- [4] THROMBOLYSIS WITH TISSUE PLASMINOGEN-ACTIVATOR IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION [J]. JOURNAL OF PROTEIN CHEMISTRY, 1986, 5 (04): : 281 - 289
- [6] HEMODYNAMIC-EFFECTS OF RECOMBINANT-TISSUE PLASMINOGEN-ACTIVATOR OR STREPTOKINASE THROMBOLYSIS IN ACUTE MYOCARDIAL-INFARCTION [J]. ZEITSCHRIFT FUR KARDIOLOGIE, 1985, 74 : 75 - 75
- [8] STREPTOKINASE OR TISSUE PLASMINOGEN-ACTIVATOR AND LEFT-VENTRICULAR FUNCTION AFTER MYOCARDIAL-INFARCTION [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (10): : 688 - 688
- [9] TISSUE-PLASMINOGEN ACTIVATOR VS PLACEBO AND STREPTOKINASE IN ACUTE MYOCARDIAL-INFARCTION [J]. ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1986, 79 (04): : 532 - 532